Imaging and sampling to study tumour biology in ovarian cancer
Studies imaging and tissue sampling to better understand high-grade serous ovarian cancer in adults.
Plain-language title generated from the registry record
Registry title: Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging
Key facts
- Where
- Montpellier, FranceSee the site
Where in France
- NOUGARET StephanieMontpellier, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Institut du Cancer de Montpellier - Val d'Aurelle
- Trial code
- NCT06084195
- Record updated
- 6 November 2026
- Original description
The objective of this study is to explore the integration of in vivo and ex vivo of MRI with histology and molecular assessments to advance non-invasive characterization of tumor heterogeneity in high-grade serous ovarian canceRead full original descriptionShow less
Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging
The objective of this study is to explore the integration of in vivo and ex vivo of MRI with histology and molecular assessments to advance non-invasive characterization of tumor heterogeneity in high-grade serous ovarian cance
Inclusion: Patient aged >18; Pathologically proven HGSOC at an advanced stage (FIGO IIIB or IIIC) which can benefit from surgery with or without prior neoadjuvant treatment; Willingness and ability to comply with planned visits, treatment plan, laboratory tests and other study procedures,; Patient who has given informed, written and express consent,; Patient affiliated with a French health insurance scheme.
Exclusion: Patient who will not have surgery; Early-stage disease (FIGO <IIIB) or presence of extraperitoneal metastases,; Patient with a history of other cancers within 5 years/10 years prior to inclusion; Patient whose regular follow-up is impossible for psychological, family, social or geographical reasons,; Patient under guardianship, curatorship or safeguarding of justice,; Pregnant and/or nursing patient,.